# 602433

AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4


Alternative titles; symbols

NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
9q34.13 Amyotrophic lateral sclerosis 4, juvenile 602433 AD 3 SETX 608465
Clinical Synopsis
   
Phenotypic Series

INHERITANCE
- Autosomal dominant
SKELETAL
Feet
- Pes cavus has been reported
NEUROLOGIC
Central Nervous System
- Difficulty walking
- Weakness of distal muscles (upper and lower limb)
- Atrophy of distal muscles
- Proximal weakness occurs later
- Lower motor neuron signs
- Upper motor neuron signs
- Hyperreflexia
- Extensor plantar responses
- Clonus may occur
- Loss of spinal cord anterior horn cells
- Corticospinal tracts with decreased myelin staining
- Pallor of dorsal columns of the spinal cord
- Diffuse axonal swelling
- No bulbar involvement
Peripheral Nervous System
- Diffuse axonal swelling
- Axonal degeneration
- No sensory abnormalities
MISCELLANEOUS
- Childhood or adolescent onset (usually less than 25 years)
- Slowly progressive
- Has also been called 'distal hereditary motor neuronopathy' (dHMN) and 'distal spinal muscular atrophy' (dSMA)
MOLECULAR BASIS
- Caused by mutation in the senataxin gene (SETX, {608465.00006})
Amyotrophic lateral sclerosis - PS105400 - 32 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.22 Frontotemporal lobar degeneration, TARDBP-related AD 3 612069 TARDBP 605078
1p36.22 Amyotrophic lateral sclerosis 10, with or without FTD AD 3 612069 TARDBP 605078
2p13.1 {Amyotrophic lateral sclerosis, susceptibility to} AR, AD 3 105400 DCTN1 601143
2q33.1 Amyotrophic lateral sclerosis 2, juvenile AR 3 205100 ALS2 606352
2q34 Amyotrophic lateral sclerosis 19 AD 3 615515 ERBB4 600543
2q35 Amyotrophic lateral sclerosis 22 with or without frontotemoral dementia AD 3 616208 TUBA4A 191110
3p11.2 Amyotrophic lateral sclerosis 17 AD 3 614696 CHMP2B 609512
5q31.2 Amyotrophic lateral sclerosis 21 AD 3 606070 MATR3 164015
5q35.3 Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 AD 3 616437 SQSTM1 601530
6q21 Amyotrophic lateral sclerosis 11 AD 3 612577 FIG4 609390
9p21.2 Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 AD 3 105550 C9orf72 614260
9p13.3 ?Amyotrophic lateral sclerosis 16, juvenile AR 3 614373 SIGMAR1 601978
9p13.3 Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia 3 613954 VCP 601023
9q34.13 Amyotrophic lateral sclerosis 4, juvenile AD 3 602433 SETX 608465
10p13 Amyotrophic lateral sclerosis 12 3 613435 OPTN 602432
12q13.12 {Amyotrophic lateral sclerosis, susceptibility to} AR, AD 3 105400 PRPH 170710
12q13.13 Amyotrophic lateral sclerosis 20 AD 3 615426 HNRNPA1 164017
12q14.2 Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 AD 3 616439 TBK1 604834
12q24.12 Spinocerebellar ataxia 2 AD 3 183090 ATXN2 601517
12q24.12 {Amyotrophic lateral sclerosis, susceptibility to, 13} AD 3 183090 ATXN2 601517
14q11.2 Amyotrophic lateral sclerosis 9 3 611895 ANG 105850
15q21.1 Amyotrophic lateral sclerosis 5, juvenile AR 3 602099 SPG11 610844
16p11.2 Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia 3 608030 FUS 137070
17p13.2 Amyotrophic lateral sclerosis 18 3 614808 PFN1 176610
18q21 Amyotrophic lateral sclerosis 3 AD 2 606640 ALS3 606640
20p13 Amyotrophic lateral sclerosis 7 2 608031 ALS7 608031
20q13.32 Amyotrophic lateral sclerosis 8 AD 3 608627 VAPB 605704
21q22.11 Amyotrophic lateral sclerosis 1 AR, AD 3 105400 SOD1 147450
22q11.23 Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 AD 3 615911 CHCHD10 615903
22q12.2 ?{Amyotrophic lateral sclerosis, susceptibility to} AR, AD 3 105400 NEFH 162230
Xp11.21 Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia XLD 3 300857 UBQLN2 300264
Not Mapped Amyotrophic lateral sclerosis, juvenile, with dementia 205200 ALSDC 205200

TEXT

A number sign (#) is used with this entry because this form of juvenile ALS is caused by mutations in the senataxin gene (SETX; 608465).

For a phenotypic description and a discussion of genetic heterogeneity of amyotrophic lateral sclerosis (ALS), see ALS1 (105400).


Description

Childhood- and adolescent-onset forms of familial ALS (see ALS1, 105400) carry the designation 'juvenile ALS.' Several forms of autosomal recessive juvenile ALS have been identified; see ALS2 (205100) and ALS5 (602099).


Clinical Features

Chance et al. (1998) studied an 11-generation pedigree with a slowly progressive, autosomal dominant form of juvenile ALS, defined as a chronic motor neuron disease characterized by combined upper and lower motor neuron symptoms and signs with onset before age 25 years. The family was originally described by Myrianthopoulos et al. (1964) as having Charcot-Marie-Tooth disease (CMT; see 118200). They had traced ancestors to 17th-century England, and the disorder was documented in 8 generations, including 52 affected persons living in Southern Maryland and nearby states. In the study of Chance et al. (1998), diagnosis of early-onset selective upper- and lower-motor-neuron involvement was established by patient history, clinical findings, and results of electrophysiologic tests. Affected persons typically manifested symptoms in the second decade of life (mean age 17 years). They initially had difficulty walking; this was followed by weakness and wasting of small muscles of the hands and distal lower limbs. By the fourth or fifth decade, affected persons had significant proximal weakness and were frequently wheelchair-bound, and by the sixth decade, they had lost useful hand function. Bulbar muscles were not symptomatically involved. Among 49 affected and 34 at-risk individuals, pathologic hyperreflexia was found in 86% of affected individuals, and 17% had extensor plantar responses. In many affected individuals, weakness of the toe and foot extensor muscles prevented interpretation of the plantar response. Forty-four of 49 subjects tested had normal sensory examinations; 5 older individuals (mean age, 51 years) had slight elevation of the vibratory threshold in the feet.

Rabin et al. (1999) reported the clinical and electrodiagnostic findings in 49 affected members and the neuropathologic findings in 2 autopsies of the Maryland family reported by Chance et al. (1998). Motor conduction studies, performed in 8 affected members, showed reduced evoked amplitudes and normal conduction parameters. Sensory conduction studies (8 individuals), quantitative sensory testing (4 individuals), and intracutaneous sensory fibers in skin biopsies (6 individuals) were normal in all patients tested. Electromyography (8 individuals) showed distal more than proximal chronic partial denervation and reinnervation. Postmortem spinal cord tissue demonstrated atrophic spinal cords with marked loss of anterior horn cells and degeneration of corticospinal tracts, as well as loss of neurons in the dorsal root ganglia and degeneration of the posterior columns. Axonal spheroids were present in the gray matter of the spinal cord, the dorsal root entry zones, and the peripheral nerves. Motor and sensory roots, as well as peripheral nerves, showed significant axonal loss. Swellings were prominent around motor neurons, probably representing changes in presynaptic terminals.

De Jonghe et al. (2002) reported 3 unrelated families with a familial disorder that they diagnosed as distal hereditary motor neuropathy (dHMN). In 2 families, the age at onset was generally less than 6 years, whereas in the third family, some patients had a later onset, including 2 with adult onset. In all families, there was distal lower limb weakness and atrophy with later involvement of the upper limbs. Bulbar muscles were spared and sensory abnormalities were absent. Most patients had brisk reflexes, and 8 of 18 had extensor plantar responses. Two families had pes cavus. De Jonghe et al. (2002) explained their diagnosis of dHMN by the distal distribution of affected muscles, the absence of sensory abnormalities, and the pattern of disease progression. They also noted the phenotypic similarities to the kindred reported by Chance et al. (1998).

By way of clinical characterization, Chen et al. (2004) stated that individuals affected with ALS4 usually have an onset of symptoms at age less than 25 years, a slow rate of progression, and a normal life span.


Mapping

Chance et al. (1998) performed a genomewide search in an 11-generation kindred with juvenile ALS and found a lod score of 18.8 at theta = 0.00 with D9S1847. Analysis of recombinant events identified D9S1831 and D9S164 as flanking markers, defining an interval of approximately 5 cM that harbors the ALS4 gene on chromosome 9q34. Thus, the gene for this disorder, designated ALS4, is genetically distinct from previously mapped familial ALS syndromes. Blair et al. (2000) refined the position of the ALS4 locus to a critical interval of less than 3 cM on 9q34.

In 3 families with a clinical syndrome with similarities to both ALS4 and dHMN, De Jonghe et al. (2002) found positive linkage (lod scores greater than 3) with markers located within the ALS4 locus region on 9q34. They narrowed the locus to a 5-cM region between markers D9S64 and D9S164.


Molecular Genetics

To identify the molecular basis of ALS4, Chen et al. (2004) tested 19 genes within the critical region for ALS4 identified by linkage studies and detected 3 different missense mutations in the senataxin gene (SETX; 608465).


Nomenclature

De Jonghe et al. (2002) commented on potential nomenclature and classification confusion of the disorders designated distal HMN, distal spinal muscular atrophy, spinal CMT, and ALS that show linkage to the ALS4 locus.


REFERENCES

  1. Blair, I. P., Bennett, C. L., Abel, A., Rabin, B. A., Griffin, J. W., Fischbeck, K. H., Cornblath, D. R., Chance, P. F. A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34. Neurogenetics 3: 1-6, 2000. [PubMed: 11085590, related citations] [Full Text]

  2. Chance, P. F., Rabin, B. A., Ryan, S. G., Ding, Y., Scavina, M., Crain, B., Griffin, J. W., Cornblath, D. R. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am. J. Hum. Genet. 62: 633-640, 1998. [PubMed: 9497266, related citations] [Full Text]

  3. Chen, Y.-Z., Bennett, C. L., Huynh, H. M., Blair, I. P., Puls, I., Irobi, J., Dierick, I., Abel, A., Kennerson, M. L., Rabin, B. A., Nicholson, G. A., Auer-Grumbach, M., Wagner, K., De Jonghe, P., Griffin, J. W., Fischbeck, K. H., Timmerman, V., Cornblath, D. R., Chance, P. F. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74: 1128-1135, 2004. [PubMed: 15106121, images, related citations] [Full Text]

  4. De Jonghe, P., Auer-Grumbach, M., Irobi, J., Wagner, K., Plecko, B., Kennerson, M., Zhu, D., De Vriendt, E., van Gerwen, V., Nicholson, G., Hartung, H.-P., Timmerman, V. Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain 125: 1320-1325, 2002. [PubMed: 12023320, related citations] [Full Text]

  5. Myrianthopoulos, N. C., Lane, M. H., Silberberg, D. H., Vincent, B. L. Nerve conduction and other studies in families with Charcot-Marie-Tooth disease. Brain 87: 589-610, 1964. [PubMed: 14236005, related citations] [Full Text]

  6. Rabin, B. A., Griffin, J. W., Crain, B. J., Scavina, M., Chance, P. F., Cornblath, D. R. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 122: 1539-1550, 1999. [PubMed: 10430837, related citations] [Full Text]


Victor A. McKusick - updated : 5/20/2004
Victor A. McKusick - updated : 5/11/2001
Victor A. McKusick - updated : 11/17/1999
Creation Date:
Victor A. McKusick : 3/10/1998
alopez : 09/22/2011
terry : 10/12/2005
alopez : 5/24/2004
terry : 5/20/2004
mgross : 3/18/2004
carol : 8/28/2003
ckniffin : 8/27/2003
mcapotos : 5/17/2001
terry : 5/11/2001
alopez : 3/3/2000
mgross : 12/6/1999
terry : 11/17/1999
alopez : 6/15/1998
dholmes : 3/30/1998
alopez : 3/10/1998

# 602433

AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4


Alternative titles; symbols

NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES


ORPHA: 357043;   DO: 0060196;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
9q34.13 Amyotrophic lateral sclerosis 4, juvenile 602433 Autosomal dominant 3 SETX 608465

TEXT

A number sign (#) is used with this entry because this form of juvenile ALS is caused by mutations in the senataxin gene (SETX; 608465).

For a phenotypic description and a discussion of genetic heterogeneity of amyotrophic lateral sclerosis (ALS), see ALS1 (105400).


Description

Childhood- and adolescent-onset forms of familial ALS (see ALS1, 105400) carry the designation 'juvenile ALS.' Several forms of autosomal recessive juvenile ALS have been identified; see ALS2 (205100) and ALS5 (602099).


Clinical Features

Chance et al. (1998) studied an 11-generation pedigree with a slowly progressive, autosomal dominant form of juvenile ALS, defined as a chronic motor neuron disease characterized by combined upper and lower motor neuron symptoms and signs with onset before age 25 years. The family was originally described by Myrianthopoulos et al. (1964) as having Charcot-Marie-Tooth disease (CMT; see 118200). They had traced ancestors to 17th-century England, and the disorder was documented in 8 generations, including 52 affected persons living in Southern Maryland and nearby states. In the study of Chance et al. (1998), diagnosis of early-onset selective upper- and lower-motor-neuron involvement was established by patient history, clinical findings, and results of electrophysiologic tests. Affected persons typically manifested symptoms in the second decade of life (mean age 17 years). They initially had difficulty walking; this was followed by weakness and wasting of small muscles of the hands and distal lower limbs. By the fourth or fifth decade, affected persons had significant proximal weakness and were frequently wheelchair-bound, and by the sixth decade, they had lost useful hand function. Bulbar muscles were not symptomatically involved. Among 49 affected and 34 at-risk individuals, pathologic hyperreflexia was found in 86% of affected individuals, and 17% had extensor plantar responses. In many affected individuals, weakness of the toe and foot extensor muscles prevented interpretation of the plantar response. Forty-four of 49 subjects tested had normal sensory examinations; 5 older individuals (mean age, 51 years) had slight elevation of the vibratory threshold in the feet.

Rabin et al. (1999) reported the clinical and electrodiagnostic findings in 49 affected members and the neuropathologic findings in 2 autopsies of the Maryland family reported by Chance et al. (1998). Motor conduction studies, performed in 8 affected members, showed reduced evoked amplitudes and normal conduction parameters. Sensory conduction studies (8 individuals), quantitative sensory testing (4 individuals), and intracutaneous sensory fibers in skin biopsies (6 individuals) were normal in all patients tested. Electromyography (8 individuals) showed distal more than proximal chronic partial denervation and reinnervation. Postmortem spinal cord tissue demonstrated atrophic spinal cords with marked loss of anterior horn cells and degeneration of corticospinal tracts, as well as loss of neurons in the dorsal root ganglia and degeneration of the posterior columns. Axonal spheroids were present in the gray matter of the spinal cord, the dorsal root entry zones, and the peripheral nerves. Motor and sensory roots, as well as peripheral nerves, showed significant axonal loss. Swellings were prominent around motor neurons, probably representing changes in presynaptic terminals.

De Jonghe et al. (2002) reported 3 unrelated families with a familial disorder that they diagnosed as distal hereditary motor neuropathy (dHMN). In 2 families, the age at onset was generally less than 6 years, whereas in the third family, some patients had a later onset, including 2 with adult onset. In all families, there was distal lower limb weakness and atrophy with later involvement of the upper limbs. Bulbar muscles were spared and sensory abnormalities were absent. Most patients had brisk reflexes, and 8 of 18 had extensor plantar responses. Two families had pes cavus. De Jonghe et al. (2002) explained their diagnosis of dHMN by the distal distribution of affected muscles, the absence of sensory abnormalities, and the pattern of disease progression. They also noted the phenotypic similarities to the kindred reported by Chance et al. (1998).

By way of clinical characterization, Chen et al. (2004) stated that individuals affected with ALS4 usually have an onset of symptoms at age less than 25 years, a slow rate of progression, and a normal life span.


Mapping

Chance et al. (1998) performed a genomewide search in an 11-generation kindred with juvenile ALS and found a lod score of 18.8 at theta = 0.00 with D9S1847. Analysis of recombinant events identified D9S1831 and D9S164 as flanking markers, defining an interval of approximately 5 cM that harbors the ALS4 gene on chromosome 9q34. Thus, the gene for this disorder, designated ALS4, is genetically distinct from previously mapped familial ALS syndromes. Blair et al. (2000) refined the position of the ALS4 locus to a critical interval of less than 3 cM on 9q34.

In 3 families with a clinical syndrome with similarities to both ALS4 and dHMN, De Jonghe et al. (2002) found positive linkage (lod scores greater than 3) with markers located within the ALS4 locus region on 9q34. They narrowed the locus to a 5-cM region between markers D9S64 and D9S164.


Molecular Genetics

To identify the molecular basis of ALS4, Chen et al. (2004) tested 19 genes within the critical region for ALS4 identified by linkage studies and detected 3 different missense mutations in the senataxin gene (SETX; 608465).


Nomenclature

De Jonghe et al. (2002) commented on potential nomenclature and classification confusion of the disorders designated distal HMN, distal spinal muscular atrophy, spinal CMT, and ALS that show linkage to the ALS4 locus.


REFERENCES

  1. Blair, I. P., Bennett, C. L., Abel, A., Rabin, B. A., Griffin, J. W., Fischbeck, K. H., Cornblath, D. R., Chance, P. F. A gene for autosomal dominant juvenile amyotrophic lateral sclerosis (ALS4) localizes to a 500-kb interval on chromosome 9q34. Neurogenetics 3: 1-6, 2000. [PubMed: 11085590] [Full Text: http://link.springer.de/link/service/journals/10048/bibs/0003001/00030001.htm]

  2. Chance, P. F., Rabin, B. A., Ryan, S. G., Ding, Y., Scavina, M., Crain, B., Griffin, J. W., Cornblath, D. R. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am. J. Hum. Genet. 62: 633-640, 1998. [PubMed: 9497266] [Full Text: https://linkinghub.elsevier.com/retrieve/pii/S0002-9297(07)63013-4]

  3. Chen, Y.-Z., Bennett, C. L., Huynh, H. M., Blair, I. P., Puls, I., Irobi, J., Dierick, I., Abel, A., Kennerson, M. L., Rabin, B. A., Nicholson, G. A., Auer-Grumbach, M., Wagner, K., De Jonghe, P., Griffin, J. W., Fischbeck, K. H., Timmerman, V., Cornblath, D. R., Chance, P. F. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74: 1128-1135, 2004. [PubMed: 15106121] [Full Text: https://linkinghub.elsevier.com/retrieve/pii/S0002-9297(07)62840-7]

  4. De Jonghe, P., Auer-Grumbach, M., Irobi, J., Wagner, K., Plecko, B., Kennerson, M., Zhu, D., De Vriendt, E., van Gerwen, V., Nicholson, G., Hartung, H.-P., Timmerman, V. Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? Brain 125: 1320-1325, 2002. [PubMed: 12023320] [Full Text: http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=12023320]

  5. Myrianthopoulos, N. C., Lane, M. H., Silberberg, D. H., Vincent, B. L. Nerve conduction and other studies in families with Charcot-Marie-Tooth disease. Brain 87: 589-610, 1964. [PubMed: 14236005] [Full Text: http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=14236005]

  6. Rabin, B. A., Griffin, J. W., Crain, B. J., Scavina, M., Chance, P. F., Cornblath, D. R. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 122: 1539-1550, 1999. [PubMed: 10430837] [Full Text: http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=10430837]


Contributors:
Victor A. McKusick - updated : 5/20/2004
Victor A. McKusick - updated : 5/11/2001
Victor A. McKusick - updated : 11/17/1999
Creation Date:
Victor A. McKusick : 3/10/1998
Edit History:
alopez : 09/22/2011
terry : 10/12/2005
alopez : 5/24/2004
terry : 5/20/2004
mgross : 3/18/2004
carol : 8/28/2003
ckniffin : 8/27/2003
mcapotos : 5/17/2001
terry : 5/11/2001
alopez : 3/3/2000
mgross : 12/6/1999
terry : 11/17/1999
alopez : 6/15/1998
dholmes : 3/30/1998
alopez : 3/10/1998